SBRT 2016

 Stage I NSCLC : No dose effect relationship for 15-33Gy  Brain metastases : Higher efficacy of SRT vs SRS Guckenberger Radiother Oncol 2013 Single fraction SRS versus fractionated stereotactic radiotherapy SBRT for stage I NSCLC Shuryak Radiother Oncol 2015 SRS for brain metastases

Matthias Guckenberger - ESTRO SBRT Course 2016 Athens

13.06.2016

14

/